| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. | Sr. VP and CFO | Common Stock | 660,909 | $931,882 | $1.41 | 23 Sep 2024 | By Trust |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | 23 Sep 2024 | 1 | $0 | 4/A | Sr. VP and CFO | 05 Nov 2024, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 15 Aug 2023 | 1 | $0 | 4 | Sr. VP and CFO | 17 Aug 2023, 16:30 |
| PLX | Protalix BioTherapeutics, Inc. | 07 Sep 2022 | 1 | $0 | 4 | Sr. VP and CFO | 09 Sep 2022, 17:03 |
| PLX | Protalix BioTherapeutics, Inc. | 25 Feb 2022 | 1 | $0 | 4 | Sr. VP and CFO | 28 Feb 2022, 16:02 |